MMJ International Holdings Files FDA Orphan Drug Application for Huntington’s Disease

Better Information For Better Health

Mr. Boise added, ” With this FDA Orphan Drug application, the most significant benefit is to the patients with Huntington’s disease since our development process can be advanced quickly to address their unmet needs. ”

MMJ International

... read more at: https://www.prweb.com/releases/2018/11/prweb15907893.htm

by